Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Organigram Global Inc.NASDAQ: OGI

Other Income / Expenses · Q2 FY2026 · quarter ended Mar 2026

Other income / expenses declines year over year

Q2 FY2026 other income / expenses of CA$8.87M fell 82.2% year over year, ahead of the -168.6% change in trailing-twelve-month other income / expenses. Sequentially, it fell 62.1% from the prior quarter.

Context

  • Other income / expenses amounted to 19.2% of revenue in FY2025, up 13.1 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -82.2% holds above the trailing-twelve-month pace of -168.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$8.87M-62.1% QoQ
Last fiscal yearSep 2025
CA$35.74M+465.9% YoY
LTMMar 2026
-CA$24.75M-168.6% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-82.2%——
1 year+465.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

CAD · from the income statement

Latest · FY2025
35.74M CAD
Year-over-year change
+465.9%

Other Income / Expenses vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -168.6% is the 7th highest of 9, against a peer median of -138.6%.
  • Other income / expenses amounts to 9.0% of revenue for OGI, versus a peer median of 4.9%.
OGI Competitors
Other Income / Expenses for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$325K USD-86.9%—1.0%
ELMDElectromed, Inc.LTM Mar 2026$266K USD-59.1%+154.5%0.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026-$1.11M USD+36.6%—0.8%
DERMJourney Medical CorporationLTM Mar 2026-$3.19M USD-139.5%—4.9%
ACBAurora Cannabis Inc.LTM Mar 2026-CA$5.83M CAD-137.8%—1.9%
OGIOrganigram Global Inc.LTM Mar 2026-CA$24.75M CAD-168.6%—9.0%
LFCRLifecore Biomedical, Inc.LTM Mar 2026-$33.6M USD——24.9%
RNACCartesian Therapeutics, Inc.LTM Mar 2026-$69.65M USD-583.2%—3924.1%
HSDTSolana CompanyLTM Mar 2026-$117.99M USD-8328.2%—1230.5%
IVAInventiva S.A.FY2025-€211.38M EUR-144.8%—4715.1%
Peer median (excluding OGI) —-138.6%+154.5%4.9%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.